My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)

Running, not enrolling

Conditions studied: Dysbiosis

In brief

My Baby Biome is an observational study that will use 600 infant stool samples to determine the biomarkers associated with a healthy infant gut. Biomarkers identified in this study will be used to develop precision probiotics and LBPs for improving infant gut health outcomes to the benefit of all infants. Parents will be asked to submit follow-up questionnaires regarding infant immune health to improve insights obtained from the data.

Key facts

Study ID

NCT05472688

Run by

Persephone Biosciences

People needed

430

Starts

2022-07-14

Expected to finish

2029-12-31

Last updated by the study team

2024-04-05

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Infants under 2 weeks or over 2 months old
• Infants given any antibiotic or probiotic treatments
• Infants delivered prematurely or admitted to the NICU outside of establishment of normal feeding
• Infants with mothers under the age of 18
• Infants with mothers known to have HIV, Hepatitis A, Hepatitis B, Hepatitis C, or SARS-CoV2

Where it is running

• Persephone Biosciences, Inc. — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.